Latest posts from our Health Matters blog Join us on LinkedIn PwC UK YouTube channel Subscribe to our RSS feed Join us on Facebook Follow PwC on Twitter

10 January 2017

A critical makeover for pharmaceutical companies - how pharma can become fit for purpose

By Dr Myrto Lee Times are challenging for the pharmaceutical sector. Whether it be payers tightening up on costs, the pressure to adapt to and adopt new technologies, challenges to traditional pricing arrangements or the ever increasing regulatory maze, companies need to find new ways to organise themselves to ensure...

07 December 2016

AAR: moving beyond the vision

By Dr Myrto Lee As we covered in our recent blog, the awaited publication of the final report of the Accelerated Access Review (AAR) sets out a bold vision to drive the development and uptake of innovative medicines and health technologies in the UK. By setting out the conditions in...

01 December 2016

What’s the role of NEDs in the emerging health landscape?

By Mike Farrar As individual NHS organisations wrestle with the conundrum of trying to operate in whole systems for the greater good, while having to protect and then defend their narrower organisational interests to regulators, the task of NEDs is becoming ever more challenging. Indeed, it’s a role which tests...

23 November 2016

Health and social care: The Autumn Statement’s great unsaid

By Quentin Cole Despite calls from across the board for additional funding for health and social care, the Chancellor’s last Autumn Statement had nothing new to offer the NHS. With just a reiteration of the £10 billion to support the Five Year Forward View, the service faces another winter under...

16 November 2016

What is blockchain and what can it do for you?

By Jonathon Marshall Imagine a world where patients, hospitals and pharma companies have a lasting and tamper-proof way to share information, secure in the knowledge that identity is known and the what and the why of the record is complete. Imagine a world where patients are warned they might fall...

04 November 2016

AMR action: Generations not years

By Jo Pisani and Rachel Armstrong Yesterday a significant conference brought together the key UK players who are involved in tackling the critical issue of antimicrobial resistance (AMR). The fact that such an event is taking place reflects the urgency that is now being attributed to this issue. In the...

03 November 2016

Redrawing the health and social care architecture

By David Morris The NHS is rightly a source of national pride in the UK. But the service today is under significant financial and demand pressures. These pressures only look set to increase and the demands on the service and on social care services provided by local councils mean we...

02 November 2016

Where next for the Accelerated Access Review?

By Dr Myrto Lee and David Weston, Strategy & At the heart of the Accelerated Access Review, an independent review on behalf of the UK Department of Health and supported by the Wellcome Trust, is a simple vision: “Getting the best technologies to patients more quickly and more cheaply, in...

23 October 2016

Solving Bed Blocking in the NHS

By Karen Finlayson Delayed transfers of care hit the highest level in August since monthly data started to be collected six years ago, the HSJ recently reported, with 6,448 patients measured as delayed. This is a serious problem in the NHS that needs to be addressed. Bed blocking is a...

10 October 2016

Transparency in the pharmaceutical sector – where next?

By Dr Myrto Lee, Director, Strategy& Within all sectors of the economy transparency is on the increase. Whether it be directors’ pay or patients choosing hospitals, the directional trend is very clear. Within the pharma sector itself there are already strong moves to increase transparency around clinical trials, reporting of...

04 October 2016

How can trusts with financial challenges turn up the pace of technological change?

By Janahan Tharmaratnam The Wachter Review is a breath of fresh air for the National Health Service. For most industries technology is a staple board level discussion topic, seen as core to the delivery of the overall business strategy. However, this is currently not the case within the NHS -...

22 September 2016

Tackling AMR needs concerted action to break down barriers

By Jo Pisani It is very welcome news that the international community through the United Nations General Assembly (UNGA) has recognised the urgent need for concerted global action around the steep rise in drug-resistant bacteria. By 2050, antimicrobial resistance (AMR) could claim an additional 10 million lives a year internationally...

19 September 2016

Are you on top of your cyber risks?

By Andi Scott Consider these three facts. First, personal healthcare records are 10 times more valuable than financial data when sold on the ‘dark web’. Second, cyber security budgets remain severely constrained across health, especially within the NHS. And third, our Global State of Information Security Survey 2016 highlighted that...

30 August 2016

Tomorrow's healthcare today: digital webcast series

By Quentin Cole Our recent World in Beta campaign discussed a number of disrupting technologies and innovations changing the health sector. To continue sharing our thoughts on the new health landscape the PwC UK Health Industries team is launching a digital webcast series. This live webcast series will explore in...

25 July 2016

The NHS - embracing best practice in good financial management

By David Morris The NHS is an institution we should all be proud of. Day in, day out, 1.7 million staff provide world-leading care to a fast-growing population with ever more complex challenges and higher expectations. But the NHS delivers its services with a budget of 0.4% of GDP less...

15 July 2016

What next for the NHS?

By Quentin Cole As Jeremy Hunt returns to his desk, Quentin Cole, PwC Health Industries Leader, reflects on the key issues facing the Health Secretary. Jeremy Hunt has been running the NHS for four years now. He knows the Service inside out. There are many great things happening in the...

07 July 2016

Brexit and the Pharma & Life Sciences industry - there will be change

By Jo Pisani While the EU referendum result won’t bring immediate change, the pharmaceutical industry faces uncertainty following the result of the EU referendum. We know there are daunting challenges ahead and future changes in the environment as a result of Brexit are currently unclear, but there are some areas...

28 June 2016

What does Brexit mean for UK Healthcare investing?

By Andrew McKechnie As the dust from the last few days starts to settle and we get back to work, we all ask “How is Brexit going to impact me and what I do?” As healthcare investors and advisors, we need to think carefully about how Brexit will impact the...

09 June 2016

Under the microscope: The recent healthcare deals market

By Brendan O’Driscoll Looking back over the last year, deals in healthcare have been driven both by changes in the wider environment, and specific trends within the sector. At the global level, the most obvious factors are demographic and social change. In developing markets like India and China the priority...

03 June 2016

Delayed Transfers of Care – Who’s to blame?

By Tim Gold and Mike Farrar The answer of course, is no one individually. For too long however, the management of Delayed Transfer of Care (DTOC) or bed-blocking has been an organisational blame game, stifling the system response required. The DTOC challenge has never been greater. The National Audit Office...